Cargando…
Antagonizing the corticotropin releasing hormone receptor 1 with antalarmin reduces the progression of endometriosis
Endometriosis is a disorder in which endometrial tissue is found outside the uterus causing pain, infertility and stress. Finding effective, non-hormonal and long-term treatments for endometriosis still remains one of the most significant challenges in the field. Corticotropin releasing hormone (CRH...
Autores principales: | Torres-Reverón, Annelyn, Rivera-Lopez, Leslie L., Flores, Idhaliz, Appleyard, Caroline B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235236/ https://www.ncbi.nlm.nih.gov/pubmed/30427841 http://dx.doi.org/10.1371/journal.pone.0197698 |
Ejemplares similares
-
Short treatment with antalarmin alters adrenal gland receptors in the rat model of endometriosis
por: Torres-Reverón, Annelyn, et al.
Publicado: (2020) -
Beyond depression and anxiety; a systematic review about the role of corticotropin-releasing hormone antagonists in diseases of the pelvic and abdominal organs
por: Pagán-Busigó, Joshua E., et al.
Publicado: (2022) -
Metabolomics in endometriosis: challenges and perspectives for future studies
por: Ortiz, Camila N, et al.
Publicado: (2021) -
Anxiety, coping skills and hypothalamus-pituitary-adrenal (HPA) axis in patients with endometriosis
por: Quiñones, Maria, et al.
Publicado: (2015) -
Antalarmin
por: Slauson, Stephen R., et al.
Publicado: (2008)